Acute respiratory failure from abused substances

Journal of Intensive Care Medicine

Volumn 19, Issue 4, 2004, Pages 183-193

  Wilson, Kevin C ^a   Saukkonen, Jussi J ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug abuse; Respiratory failure

Indexed keywords

ALCOHOL; AMPHETAMINE; BENZODIAZEPINE DERIVATIVE; COCAINE; OPIATE DERIVATIVE; AMPHETAMINE DERIVATIVE; CANNABIS; NARCOTIC AGENT; SOLVENT;

ACUTE RESPIRATORY FAILURE; BREATHING MUSCLE; BRONCHOSPASM; CENTRAL NERVOUS SYSTEM DEPRESSION; DRUG DEPENDENCE; HUMAN; LUNG ASPIRATION; LUNG EDEMA; LUNG HEMORRHAGE; LUNG VASOCONSTRICTION; METABOLIC ACIDOSIS; PATHOPHYSIOLOGY; PNEUMOTHORAX; PRIORITY JOURNAL; REVIEW; SEIZURE; STROKE; SUBSTANCE ABUSE; ACUTE DISEASE; ADDICTION; ADULT RESPIRATORY DISTRESS SYNDROME; ALCOHOLISM; DRUG EFFECT; INHALATIONAL DRUG ADMINISTRATION; INTENSIVE CARE; METHODOLOGY; PNEUMONIA; RESPIRATORY FAILURE; RESPIRATORY FUNCTION; RESPIRATORY TRACT INFECTION;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ALCOHOLISM; AMPHETAMINES; BENZODIAZEPINES; BRONCHIAL SPASM; CANNABIS; COCAINE; HUMANS; INTENSIVE CARE; NARCOTICS; PNEUMONIA; PNEUMOTHORAX; PULMONARY EDEMA; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY; RESPIRATORY PHYSIOLOGY; RESPIRATORY TRACT INFECTIONS; SOLVENTS; SUBSTANCE-RELATED DISORDERS;

EID: 16544366779     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066604263918     Document Type: Review

References (88)

1. Substance Abuse and Mental Health Services Administration. Results From the 2001 Rational Household Survey on Drug Abuse: Volume I. Summary of National Findings. Office of Applied Studies, NHSDA Series H-17, 2002, DHHS Publication No. SMA 02-3758. Rockville, Md: Substance Abuse and Mental Health Services Administration.
2. Drug Abuse Warning Network Report. Hospital Visits and Deaths. DAWN series D-22, 2001. DHHS Publication no. SMA 03-3779.
3. Crofton J, Douglas A. The structure and function of the respiratory tract. In: Crofton J, Douglas A, eds. Respiratory Diseases. 3rd ed. Boston, Mass: Blackwell Scientific; 1981:1-79.
4. Adrogue HJ, Tobin MJ. Respiratory Failure. Cambridge, Mass: Blackwell Science; 1997.
5. Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2001;32:280-299.
6. Perez JA Jr, Arsura EL, Strategos S. Methamphetamine-related stroke: four cases. J Emerg Med. 1999;17:469-471.
7. Siegel AJ, Sholar MB, Mendelson JH, et al. Cocaine-induced erythrocytosis and increase in von Willebrand factor: evidence for drug-related blood doping and prothrombotic effects. Arch Intern Med. 1999;159:1925-1929.
8. Kaku DA, Lowenstein DH. Emergence of recreational drug abuse as a major risk factor for stroke in young adults. Ann Intern Med. 1990;113:821-327.
9. Levine SR, Brust JC, Futrell N, et al. Cerebrovascular complications of the use of the "crack" form of alkaloidal cocaine. N Engl J Med. 1990;323:699-704.
10. Klonoff DC, Andrews BT, Obana WG. Stroke associated with cocaine use. Arch Neurol. 1989;46:989-993.
11. Spivey WH, Euerle B. Neurological complications of cocaine abuse. Ann Emerg Med. 1990;19:1422-1428.
12. Earnest MP. Seizures. Neurol Clin. 1993;11:563-575.
13. Derlet RW, Heischober B. Methamphetamine: stimulant of the 1990s? Western J Med. 1990;153:625-628.
14. Shannon M, Quang LS. Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: a case report and review of the literature. Pediatr Emerg Care. 2000;16:435-440.
15. Weinhouse GL, Manaker S, Friedman S. Alcohol withdrawal syndromes. In: Rose BD, ed. UpToDate Online 10.1. Wellesley, Mass: UpToDate; 2002.
16. McKenzie DK, Bellemare F. Respiratory muscle fatigue. Adv Exp Med Biol. 1995;384:401-414.
17. Vianna LG, Koulouris N, Lanigan C, Moxham J. Effect of acute hypercapnia on limb muscle contractility in humans. J Appl Physiol. 1990;69:1486-1493.
18. Juan G, Calverly P, Talamo C, Schnader J, Roussos C. Effect of carbon dioxide on diaphragmatic function in the human being. N Engl J Med. 1984;310:874-879.
19. Westerblad H, Lee JA, Lannergren J, Allen DG. Cellular mechanisms of fatigue in skeletal muscle. Am J Physiol. 1991;261:C195-C209.
20. Burns MJ, Schwartzstein RM. Decontamination of poisoned patients. In: Rose BD, ed. UpToDate 9.2. Wellesley, Mass: UpToDate; 2001.
21. Bynum LJ, Pierce AK. Pulmonary aspiration of gastric contents. Am Rev Respir Dis. 1976;114:1129.
22. James CF, Modell JH, Gibbs CP, Kuck EJ, Ruiz BC. Pulmonary aspiration: effect of volume and pH in rates. Anesth Analg. 1984;63:655.
23. Bartlett JG. Anaerobic bacterial infections of the lung and pleural space. Clin Infect Dis. 1993;4:S248-S255.
24. Finegold SM. Aspiration pneumonia. Rev Infect Dis. 1991;9:S737.
25. Lorber B, Swenson RM. Bacteriology of aspiration pneumonia: a prospective study of community and hospital-acquired cases. Ann Intern Med. 1974;81:329-331.
26. Levison ME, Mangura CT, Lorber B, et al. Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann Intern Med. 1983;98:466-471.
27. Gudiol F, Manressa F, Pallares R, et al. Clindamycin vs. penicillin for anaerobic lung infections. Arch Intern Med. 1990;158:2525.
28. Eykyn SJ. The therapeutic use of metronidazole in anaerobic infection: six years' experience in a London hospital. Surgery. 1983;93:209-214.
29. Perlino CA. Metronidazole vs. Clindamycin treatment of anaerobic pulmonary infection: failure of metronidazole therapy. Arch Intern Med. 1981;141:1424-1427.
30. Muder R. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. Am J Med. 1998;105:319-330.
31. O'Donnell AE, Pappas LS. Pulmonary complications of intravenous drug abuse. Chest. 1988;94:251-253.
32. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301-1308.
33. Brower RG, Rubenfeld GD. Lung-protective ventilation strategies in acute lung injury. Crit Care Med. 2003;31(suppl 4):S312-S316.
34. Rosenow EC. The spectrum of drug-induced pulmonary disease. Ann Intern Med. 1972;77:977.
35. Rosenow EC. Environmental and occupational disorders. In: Murray JF, Nadel JA, eds. Textbook of Respiratory Medicine. 2nd ed. Philadelphia, Pa: WB Saunders; 1994:2127.
36. Hughes S, Calverly PMA. Heroin inhalation and asthma. Br Med J. 1988;297:1511-1512.
37. Ghats AH, Mahler J. Asthma in opiate addicts. J Psych Res. 1987;31:41-44.
38. Rome LA, Lippmann ML, Dalsey WC, Taggart P, Pemerantz S. Prevalence of cocaine use and its impact on asthma exacerbation in an urban population. Chest. 2000;117:1324-1329.
39. Tashkin DP. Airway effects of marijuana, cocaine, and other inhaled illicit agents. Curr Opin Pulm Med. 2001;7:43-61
40. Vally H, de Klerk N, Thompson PJ. Alcoholic drinks: important triggers for asthma. J Allergy Clin Immunol. 2000;105;462-467.
41. Osborn HH, Tang M, Bradley K, Duncan BR. New-onset bronchospasm or recrudescence of asthma associated with cocaine abuse. Acad Emerg Med. 1997;4:689-692.
42. Louria DB, Hensle T, Rose J. The major medical complications of heroin addiction. Ann Intern Med. 1967;67:1-22.
43. Lewis JW Jr, Groux N, Elliott JP Jr, Jara FM, Obeid FN, Magilligan DJ Jr. Complications of attempted central venous injections performed by drug abusers. Chest. 1980;78:613-617.
44. Aguado JM, Arjona R, Ugarte P. Septic pulmonary emboli: a rare cause of bilateral pneumothorax in drug abusers. Chest. 1990;98:1302-1304.
45. Albertson TE, Walby WF, Derlet RW. Stimulant-induced pulmonary toxicity. Chest. 1995;108:1140-1149.
46. Hojer J. Severe metabolic acidosis in the alcoholic: differential diagnosis and management. Hum Exp Toxicol. 1996;15:482-488.
47. Ayers JG, Clark TJ. Alcoholic drinks and asthma: a survey. Br J Dis Chest. 1983;77:370-375.
48. Vally, H, Carr A, El-Saleh J, Thompson P. Wine-induced asthma: a placebo controlled assessment of its pathogenesis. J Allergy Clin Immunol. 1999;103:41-46.
49. Fujimura M, Myou S, Kamio Y, et al. Increased airway responsiveness to acetaldehyde in asthmatic subjects with alcohol-induced bronchoconstriction. Eur Respir J. 1999;14:19-22.
50. Shimoda T, Kohno S, Takao A, et al. Investigation of the mechanism of alcohol-induced bronchial asthma. J Allergy Clin Immunol. 1996;97:74-84.
51. Gong H Jr, Tashkin DP, Calvarese BM. Alcohol-induced bronchospasm in an asthmatic patient: pharmacologic evaluation of the mechanism. Chest. 1981;80:167-173.
52. Takao A, Shimoda T, Kohno S, Asai S, Harda S. Correlation between alcohol-induced asthma and acetaldehyde dehydrogenase-2 genotype. J Allergy Clin Immunol. 1998;101:576-580.
53. Moss M, Guidot DM, Wong-Lambertina M, Ten Hoor T, Perez RL, Brown LA. The effects of chronic alcohol abuse on pulmonary glutathione homeostasis. Am J Respir Crit Care Med. 2000;161:414-419.
54. Perloff JK, Whereat AF. Alcohol in toxic congestive cardiomyopathy. Hosp Pract. 1976;11:33-36.
55. Chu J, Wang RY, Hill N. Update in clinical toxicology. Am J Respir Crit Care Med. 2002;166:9-15.
56. Jacobsen D, McMartin KE. Methanol and ethylene glycol poisonings: mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol. 1986;1:309-334.
57. Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002;40:415-446.
58. Jaffe J, Martin WR. Opioid analgesics and antagonists. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. Elmsford, NY: Pergamon; 1990:362-396.
59. Sporer KA. Acute heroin overdose. Ann Intern Med. 1999;130:584-590.
60. Bradberry JC, Raebel MA. Continuous infusion of naloxone in the treatment of narcotic overdose. Drug Intell Clin Pharm. 1981;15:945-950.
61. Wang DS, Sternbach G, Varon J. Nalmefene: a long-acting opioid antagonist-clinical applications in emergency medicine. J Emerg Med. 1998;16:471-475.
62. Jay SJ, Johanson WG, Pierce AK. Respiratory complications of overdose with sedative drugs. Am Rev Respir Dis. 1975;112:591.
63. Weinbroum AA, Flaishon R, Sorkine P, et al. A risk-benefit assessment of flumazenil in the management of benzodiazepine overdose. Drug Saf. 1997;17:81.
64. Graudins A, Aaron CK. Sedative-hypnotic poisoning. In: Irwin RS, Cerra FB, Rippe JM, eds. Intensive Care Medicine. Philadelphia: Pa Lipincott-Raven; 1999:1782.
65. Wyse DG. Deliberate inhalation of volatile hydrocarbons: a review. Can Med Assoc J. 1973;108:71-74.
66. Gillman MA. Nitrous oxide, an opioid addictive agent: review of the evidence. Am J Med. 1986;81:97-102.
67. Linden CH. Volatile substances of abuse. Emerg Med Clin North Am. 1990;8:559-578.
68. Baur X. Hypersensitivity pneumonitis (extrinsic allergic alveolitis) induced by isocyanates. J Allergy Clin Immunol. 1995;95:1004-1010.
69. Stevens DC, Campbell JP, Carter JE, Watson WA. Acid-base abnormalities associated with cocaine toxicity in emergency department patients. J Toxicol Clin Toxicol. 1994;32:31-39.
70. Ettinger NA, Albin RJ. A review of the respiratory effects of smoking cocaine. Am J Med. 1989;87:664-668.
71. Osborn HH, Tang M, Bradley K, Duncan BR. New onset bronchospasm or recrudescence of asthma associated with cocaine abuse. Acad Emerg Med. 1997;4:689-692.
72. Forrester JM, Steele AW, Waldron JA, Parsons PE. Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathologic findings. Am Rev Respir Dis. 1990;142:462-467.
73. Bailey ME, Fraire AE, Greenberg SD, Barnard J, Cagle PT. Pulmonary histopathology in cocaine abusers. Hum Pathol. 1994;25:203-207.
74. Smith WS, Matthay MA. Evidence for a hydrostatic mechanism in human neurogenic pulmonary edema. Chest. 1997;111:1326-1333.
75. Kleerup EC, Wong M, Marques-Magallanes JA, Goldman MD, Tashkin DP. Acute effects of intravenous cocaine on pulmonary artery pressure and cardiac index in habitual crack smokers. Chest. 1997;111:30-35.
76. Tashkin DP, Kleerup EC, Koyal SN, Marques JA, Goldman MD. Acute effects of inhaled and i.v. cocaine on airway dynamics. Chest. 1996;110:904-910.
77. Garcia-Rostan Y, Perez GM, Garcia Bragado F, Puras Gil AM. Pulmonary hemorrhage and antiglomerular basement membrane antibody-mediated glomerulonephritis after exposure to smoked cocaine (crack): a case report and review of the literature. Pathol Int. 1997;47:692-697.
78. Tashkin DP, Gorelick D, Khalsa ME, Simmons M, Chang P. Respiratory effects of cocaine freebasing among habitual cocaine users. J Addict Dis. 1992;11:59-70.
79. Smith GT, McClaughry PL, Purkey J, Thompson W. Crack cocaine mimicking pulmonary embolism on pulmonary ventilation/perfusion lung scan: a case report. Clin Nuclear Med. 1995;20:65-68.
80. Om A. Cardiovascular complications of cocaine. Am J Med Sci. 1992;303:333-339.
81. Lewman LV. Fatal pulmonary hypertension from intravenous injection of methylphenidate (Ritalin) tablets. Hum Pathol. 1972;3:67-70.
82. Kissner DG, Lawrence WD, Selis JE, Flint A. Crack lung: pulmonary disease caused by cocaine abuse. Am Rev Respir Dis. 1987;136:1250-1252.
83. Meleca RJ, Burgio DL, Carr RM, Lolachi CM. Mucosal injuries of the upper aerodigestive tract after smoking crack or freebase cocaine. Laryngoscope. 1997;107:620-625.
84. Reino AJ, Lawson W. Upper airway distress in crack-cocaine users. Otolaryngol Head Neck Surg. 1993;109:937-940.
85. Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry. 2001;178:101-106.
86. Birrer RB. Calderon pneumothorax, pneumomediastinum, and pneumopericardium following Valsalva's maneuver during marijuana smoking. N Y State J Med. 1984;84:619-620.
87. Szyper-Kravitz M, Lang R, Manor Y, Lahav M. Early invasive pulmonary aspergillosis in a leukemia patient linked to aspergillus contaminated marijuana smoking. Leuk Lymphoma. 2001;42:1433-1437.
88. Llamas R, Hart DR, Schneider NS. Allergic bronchopulmonary aspergillosis associated with smoking moldy marihuana. Chest. 1978;73:871-872.